{"id":"https://openalex.org/W2124355658","doi":"https://doi.org/10.1016/s1473-3099(13)70025-2","title":"Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action","display_name":"Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action","alternate_titles":[],"publication_year":2013,"publication_date":"2013-03-24","ids":{"openalex":"https://openalex.org/W2124355658","doi":"https://doi.org/10.1016/s1473-3099(13)70025-2","mag":"2124355658","pmid":"https://pubmed.ncbi.nlm.nih.gov/23531393","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4012744"},"language":"en","primary_location":{"id":"doi:10.1016/s1473-3099(13)70025-2","doi":"https://doi.org/10.1016/s1473-3099(13)70025-2","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1473-3099(13)70025-2","pdf_url":"https://doi.org/10.1016/s1473-3099(13)70025-2","source":{"id":"https://openalex.org/S23772524","display_name":"The Lancet Infectious Diseases","issn_l":"1473-3099","issn":["1473-3099","1474-4457"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Infectious Diseases","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2124355658"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/s1473-3099(13)70025-2","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057471281","display_name":"William A. Wells","orcid":"https://orcid.org/0000-0003-4360-1263","observed_orcids":["https://orcid.org/0000-0003-4360-1263"]},"institutions":[{"id":"https://openalex.org/I2802472728","display_name":"TB Alliance","ror":"https://ror.org/03ms7cf36","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2802472728"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William A Wells","raw_affiliation_strings":["Global Alliance for TB Drug Development, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Alliance for TB Drug Development, New York, NY, USA","institution_ids":["https://openalex.org/I2802472728"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045061550","display_name":"Catharina C. Boehme","orcid":"https://orcid.org/0000-0002-2200-8674","observed_orcids":["https://orcid.org/0000-0002-2200-8674"]},"institutions":[{"id":"https://openalex.org/I1281389954","display_name":"FIND","ror":"https://ror.org/05tcsqz68","country_code":"CH","type":"nonprofit","lineage":["https://openalex.org/I1281389954"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Catharina C Boehme","raw_affiliation_strings":["Foundation for Innovative New Diagnostics, Geneva, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation for Innovative New Diagnostics, Geneva, Switzerland","institution_ids":["https://openalex.org/I1281389954"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025118287","display_name":"Frank G. J. Cobelens","orcid":"https://orcid.org/0000-0002-4367-1133","observed_orcids":["https://orcid.org/0000-0002-4367-1133"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]},{"id":"https://openalex.org/I4210124406","display_name":"Amsterdam Institute for Global Health and Development","ror":"https://ror.org/037n2rm85","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210124406"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Frank GJ Cobelens","raw_affiliation_strings":["Department of Global Health, Academic Medical Center, and Amsterdam Institute of Global Health and Development, Amsterdam, Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Global Health, Academic Medical Center, and Amsterdam Institute of Global Health and Development, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2802928900","https://openalex.org/I4210124406"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014780748","display_name":"Colleen Daniels","orcid":"https://orcid.org/0000-0002-4874-0329","observed_orcids":["https://orcid.org/0000-0002-4874-0329"]},"institutions":[{"id":"https://openalex.org/I2801662763","display_name":"Treatment Action Group","ror":"https://ror.org/03w4sj937","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2801662763"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Colleen Daniels","raw_affiliation_strings":["Treatment Action Group, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Treatment Action Group, New York, NY, USA","institution_ids":["https://openalex.org/I2801662763"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066677332","display_name":"David W. Dowdy","orcid":"https://orcid.org/0000-0003-0481-7475","observed_orcids":["https://orcid.org/0000-0003-0481-7475"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Dowdy","raw_affiliation_strings":["Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA","institution_ids":["https://openalex.org/I145311948"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113664138","display_name":"Elizabeth Gardiner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802472728","display_name":"TB Alliance","ror":"https://ror.org/03ms7cf36","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2802472728"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Gardiner","raw_affiliation_strings":["Global Alliance for TB Drug Development, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Alliance for TB Drug Development, New York, NY, USA","institution_ids":["https://openalex.org/I2802472728"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064690204","display_name":"J. Gheuens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1303444417","display_name":"Gates Foundation","ror":"https://ror.org/0456r8d26","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1303444417"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jan Gheuens","raw_affiliation_strings":["Bill & Melinda Gates Foundation, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bill & Melinda Gates Foundation, Seattle, WA, USA","institution_ids":["https://openalex.org/I1303444417"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100672885","display_name":"Peter S. Kim","orcid":"https://orcid.org/0000-0003-1075-946X","observed_orcids":["https://orcid.org/0000-0003-1075-946X"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210134534","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210134534"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Kim","raw_affiliation_strings":["Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210134534"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106237219","display_name":"Michael E. Kimerling","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1303444417","display_name":"Gates Foundation","ror":"https://ror.org/0456r8d26","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1303444417"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael E Kimerling","raw_affiliation_strings":["Bill & Melinda Gates Foundation, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bill & Melinda Gates Foundation, Seattle, WA, USA","institution_ids":["https://openalex.org/I1303444417"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044485195","display_name":"Barry N. Kreiswirth","orcid":"https://orcid.org/0000-0002-0243-131X","observed_orcids":["https://orcid.org/0000-0002-0243-131X"]},"institutions":[{"id":"https://openalex.org/I4405286694","display_name":"University of Medicine and Dentistry of New Jersey","ror":"https://ror.org/02tvvmk84","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142","https://openalex.org/I4405286694"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barry Kreiswirth","raw_affiliation_strings":["University of Medicine and Dentistry of New Jersey, Newark, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Medicine and Dentistry of New Jersey, Newark, NJ, USA","institution_ids":["https://openalex.org/I4405286694"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052458295","display_name":"Christian Lienhardt","orcid":"https://orcid.org/0000-0003-0233-893X","observed_orcids":["https://orcid.org/0000-0003-0233-893X"]},"institutions":[{"id":"https://openalex.org/I4210105654","display_name":"World Health Organization","ror":"https://ror.org/01f80g185","country_code":"CH","type":"government","lineage":["https://openalex.org/I4210105654"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Christian Lienhardt","raw_affiliation_strings":["Stop TB Department, WHO, Geneva, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stop TB Department, WHO, Geneva, Switzerland","institution_ids":["https://openalex.org/I4210105654"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079086838","display_name":"Khisimuzi E. Mdluli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802472728","display_name":"TB Alliance","ror":"https://ror.org/03ms7cf36","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I2802472728"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Khisi Mdluli","raw_affiliation_strings":["Global Alliance for TB Drug Development, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Alliance for TB Drug Development, New York, NY, USA","institution_ids":["https://openalex.org/I2802472728"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019369748","display_name":"Madhukar Pai","orcid":"https://orcid.org/0000-0003-3667-4536","observed_orcids":["https://orcid.org/0000-0003-3667-4536"]},"institutions":[{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Madhukar Pai","raw_affiliation_strings":["Department of Epidemiology and Biostatistics, McGill University, Montreal, QC, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology and Biostatistics, McGill University, Montreal, QC, Canada","institution_ids":["https://openalex.org/I5023651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069109715","display_name":"Mark D. Perkins","orcid":"https://orcid.org/0000-0003-4326-8384","observed_orcids":["https://orcid.org/0000-0003-4326-8384"]},"institutions":[{"id":"https://openalex.org/I1281389954","display_name":"FIND","ror":"https://ror.org/05tcsqz68","country_code":"CH","type":"nonprofit","lineage":["https://openalex.org/I1281389954"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Mark D Perkins","raw_affiliation_strings":["Foundation for Innovative New Diagnostics, Geneva, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation for Innovative New Diagnostics, Geneva, Switzerland","institution_ids":["https://openalex.org/I1281389954"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109348882","display_name":"TREVOR F. PETER","orcid":"https://orcid.org/0000-0002-3320-235X","observed_orcids":["https://orcid.org/0000-0002-3320-235X"]},"institutions":[{"id":"https://openalex.org/I4210099038","display_name":"Clinton Health Access Initiative","ror":"https://ror.org/013mr5k03","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210099038"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Trevor Peter","raw_affiliation_strings":["Clinton Health Access Initiative, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinton Health Access Initiative, Boston, MA, USA","institution_ids":["https://openalex.org/I4210099038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051964033","display_name":"Matteo Zignol","orcid":"https://orcid.org/0000-0003-0516-3346","observed_orcids":["https://orcid.org/0000-0003-0516-3346"]},"institutions":[{"id":"https://openalex.org/I4210105654","display_name":"World Health Organization","ror":"https://ror.org/01f80g185","country_code":"CH","type":"government","lineage":["https://openalex.org/I4210105654"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Matteo Zignol","raw_affiliation_strings":["Stop TB Department, WHO, Geneva, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stop TB Department, WHO, Geneva, Switzerland","institution_ids":["https://openalex.org/I4210105654"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050606821","display_name":"Alimuddin I. Zumla","orcid":"https://orcid.org/0000-0002-5111-5735","observed_orcids":["https://orcid.org/0000-0002-5111-5735"]},"institutions":[{"id":"https://openalex.org/I2802614804","display_name":"University Teaching Hospital","ror":"https://ror.org/03zn9xk79","country_code":"ZM","type":"healthcare","lineage":["https://openalex.org/I2802614804"]},{"id":"https://openalex.org/I33278361","display_name":"University of Zambia","ror":"https://ror.org/03gh19d69","country_code":"ZM","type":"education","lineage":["https://openalex.org/I33278361"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB","ZM"],"is_corresponding":false,"raw_author_name":"Alimuddin Zumla","raw_affiliation_strings":["University College London , London , United Kingdom","Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, London, UK","University of Zambia-University College London Medical School (UNZA-UCLMS) Research and Training Project, University Teaching Hospital, Lusaka, Zambia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University College London , London , United Kingdom","institution_ids":["https://openalex.org/I45129253"]},{"raw_affiliation_string":"Centre for Clinical Microbiology, Division of Infection and Immunity, University College London, London, UK","institution_ids":["https://openalex.org/I45129253"]},{"raw_affiliation_string":"University of Zambia-University College London Medical School (UNZA-UCLMS) Research and Training Project, University Teaching Hospital, Lusaka, Zambia","institution_ids":["https://openalex.org/I2802614804","https://openalex.org/I33278361","https://openalex.org/I45129253"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022691579","display_name":"Marco L. Schito","orcid":"https://orcid.org/0000-0003-0113-4628","observed_orcids":["https://orcid.org/0000-0003-0113-4628"]},"institutions":[{"id":"https://openalex.org/I1280259254","display_name":"Henry M. Jackson Foundation","ror":"https://ror.org/04q9tew83","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I1280259254"]},{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210134534","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210134534"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Marco Schito","raw_affiliation_strings":["Henry M Jackson Foundation-Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Henry M Jackson Foundation-Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1280259254","https://openalex.org/I1299303238","https://openalex.org/I4210134534"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":17,"corresponding_author_ids":["https://openalex.org/A5022691579"],"corresponding_institution_ids":["https://openalex.org/I1280259254","https://openalex.org/I1299303238","https://openalex.org/I4210134534"],"apc_list":{"value":7280,"currency":"USD","value_usd":7280},"apc_paid":{"value":7280,"currency":"USD","value_usd":7280},"fwci":1.4517,"has_fulltext":true,"cited_by_count":66,"citation_normalized_percentile":{"value":0.8138942,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"13","issue":"5","first_page":"449","last_page":"458"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10038","display_name":"Tuberculosis Research and Epidemiology","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11381","display_name":"Infectious Diseases and Tuberculosis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11316","display_name":"Mycobacterium research and diagnosis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tuberculosis","display_name":"tuberculosis","score":0.7139999866485596},{"id":"https://openalex.org/keywords/drug-susceptibility-testing","display_name":"drug susceptibility testing","score":0.7749999761581421},{"id":"https://openalex.org/keywords/antimicrobial-resistance","display_name":"antimicrobial resistance","score":0.7860000133514404},{"id":"https://openalex.org/keywords/molecular-mechanisms-of-resistance","display_name":"molecular mechanisms of resistance","score":0.7590000033378601},{"id":"https://openalex.org/keywords/resistance-mutations","display_name":"resistance mutations","score":0.7239999771118164},{"id":"https://openalex.org/keywords/strain-collection","display_name":"strain collection","score":0.6700000166893005},{"id":"https://openalex.org/keywords/tuberculosis-surveillance","display_name":"tuberculosis surveillance","score":0.593999981880188},{"id":"https://openalex.org/keywords/resource-limited-settings","display_name":"resource-limited settings","score":0.8489999771118164},{"id":"https://openalex.org/keywords/clinical-decision-making","display_name":"clinical decision-making","score":0.6060000061988831}],"concepts":[{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.7289931178092957},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6937801837921143},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.6098182797431946},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5498674511909485},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5137258768081665},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.493656724691391},{"id":"https://openalex.org/C3020294253","wikidata":"https://www.wikidata.org/wiki/Q1189184","display_name":"Drug resistant tuberculosis","level":4,"score":0.4392927587032318},{"id":"https://openalex.org/C176553487","wikidata":"https://www.wikidata.org/wiki/Q7855819","display_name":"Turnaround time","level":2,"score":0.43613627552986145},{"id":"https://openalex.org/C2777975735","wikidata":"https://www.wikidata.org/wiki/Q130971","display_name":"Mycobacterium tuberculosis","level":3,"score":0.4162346124649048},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.3704606890678406},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35776954889297485},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.25395551323890686},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17406365275382996},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.11287719011306763},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C111919701","wikidata":"https://www.wikidata.org/wiki/Q9135","display_name":"Operating system","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000465","descriptor_name":"Algorithms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000995","descriptor_name":"Antitubercular Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009169","descriptor_name":"Mycobacterium tuberculosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009169","descriptor_name":"Mycobacterium tuberculosis","qualifier_ui":"Q000472","qualifier_name":"pathogenicity","is_major_topic":false},{"descriptor_ui":"D011159","descriptor_name":"Population Surveillance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014376","descriptor_name":"Tuberculosis","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D014376","descriptor_name":"Tuberculosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014376","descriptor_name":"Tuberculosis","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018088","descriptor_name":"Tuberculosis, Multidrug-Resistant","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D018088","descriptor_name":"Tuberculosis, Multidrug-Resistant","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D024901","descriptor_name":"Drug Resistance, Multiple, Bacterial","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":9,"locations":[{"id":"doi:10.1016/s1473-3099(13)70025-2","doi":"https://doi.org/10.1016/s1473-3099(13)70025-2","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1473-3099(13)70025-2","pdf_url":"https://doi.org/10.1016/s1473-3099(13)70025-2","source":{"id":"https://openalex.org/S23772524","display_name":"The Lancet Infectious Diseases","issn_l":"1473-3099","issn":["1473-3099","1474-4457"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Infectious Diseases","raw_type":"journal-article"},{"id":"pmid:23531393","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23531393","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet. Infectious diseases","raw_type":"Journal Article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/b50a9ee9-31d8-49ab-9f94-6da20ce6ab60","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/b50a9ee9-31d8-49ab-9f94-6da20ce6ab60","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Wells, W A, Boehme, C C, Cobelens, F G J, Daniels, C, Dowdy, D, Gardiner, E, Gheuens, J, Kim, P, Kimerling, M E, Kreiswirth, B, Lienhardt, C, Mdluli, K, Pai, M, Perkins, M D, Peter, T, Zignol, M, Zumla, A & Schito, M 2013, 'Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action', Lancet infectious diseases, vol. 13, no. 5, pp. 449-458. https://doi.org/10.1016/S1473-3099(13)70025-2","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:europepmc.org:2991422","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4012744","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4012744","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4012744/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Lancet Infect Dis","raw_type":"Text"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/834662e7-c82c-4558-97fb-da7ec0fbb3bb","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/alignment-of-new-tuberculosis-drug-regimens-and-drug-susceptibility-testing-a-framework-for-action(834662e7-c82c-4558-97fb-da7ec0fbb3bb).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Lancet infectious diseases, 13(5), 449 - 458. Lancet Publishing Group","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1389346","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/1389346/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"LANCET INFECTIOUS DISEASES , 13 (5) pp. 449-458. (2013)","raw_type":"Article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1393900","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/1393900/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The Lancet Infectious Diseases , 13 (5) pp. 449-458. (2013)","raw_type":"Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.663.1778","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.663.1778","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://tbevidence.org/wp-content/uploads/2013/05/Wells-LID-2013.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1016/s1473-3099(13)70025-2","doi":"https://doi.org/10.1016/s1473-3099(13)70025-2","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1473-3099(13)70025-2","pdf_url":"https://doi.org/10.1016/s1473-3099(13)70025-2","source":{"id":"https://openalex.org/S23772524","display_name":"The Lancet Infectious Diseases","issn_l":"1473-3099","issn":["1473-3099","1474-4457"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4412208123","display_name":null,"funder_award_id":"HHSN272200800014C)","funder_id":"https://openalex.org/F4320306085","funder_display_name":"U.S. Department of Health and Human Services"},{"id":"https://openalex.org/G4597261937","display_name":"A User-Friendly Epidemic-Economic Model of Diagnostic Tests for Tuberculosis","funder_award_id":"R21AI101152","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G7940782042","display_name":null,"funder_award_id":"HHSN272200800014C","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G8838525055","display_name":null,"funder_award_id":"Z99 AI999999","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320306085","display_name":"U.S. Department of Health and Human Services","ror":"https://ror.org/033jnv181"},{"id":"https://openalex.org/F4320306115","display_name":"United States Agency for International Development","ror":"https://ror.org/01n6e6j62"},{"id":"https://openalex.org/F4320306137","display_name":"Bill and Melinda Gates Foundation","ror":"https://ror.org/0456r8d26"},{"id":"https://openalex.org/F4320309507","display_name":"San Diego State University","ror":"https://ror.org/0264fdx42"},{"id":"https://openalex.org/F4320311018","display_name":"Irish Aid","ror":"https://ror.org/03kyawa63"},{"id":"https://openalex.org/F4320311430","display_name":"London School of Hygiene and Tropical Medicine","ror":"https://ror.org/00a0jsq62"},{"id":"https://openalex.org/F4320319996","display_name":"Department for International Development, UK Government","ror":"https://ror.org/05rf29967"},{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320320719","display_name":"Department of Science and Technology, Ministry of Science and Technology, India","ror":"https://ror.org/0101xrq71"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332163","display_name":"U.S. Food and Drug Administration","ror":"https://ror.org/034xvzb47"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2124355658.pdf","grobid_xml":"https://content.openalex.org/works/W2124355658.grobid-xml"},"referenced_works_count":56,"referenced_works":["https://openalex.org/W57368190","https://openalex.org/W113437334","https://openalex.org/W206109427","https://openalex.org/W301803583","https://openalex.org/W1125319649","https://openalex.org/W1213717835","https://openalex.org/W1235477125","https://openalex.org/W1566877505","https://openalex.org/W1573042727","https://openalex.org/W1606105143","https://openalex.org/W1652831512","https://openalex.org/W1694189029","https://openalex.org/W1971252437","https://openalex.org/W1977881210","https://openalex.org/W1993044233","https://openalex.org/W1995225866","https://openalex.org/W1996794817","https://openalex.org/W2012723624","https://openalex.org/W2014688912","https://openalex.org/W2025415062","https://openalex.org/W2026766410","https://openalex.org/W2056637768","https://openalex.org/W2059116761","https://openalex.org/W2066218616","https://openalex.org/W2083487129","https://openalex.org/W2095718569","https://openalex.org/W2096209715","https://openalex.org/W2099109129","https://openalex.org/W2099338126","https://openalex.org/W2101080794","https://openalex.org/W2101671856","https://openalex.org/W2101903135","https://openalex.org/W2104750364","https://openalex.org/W2107446706","https://openalex.org/W2110335021","https://openalex.org/W2124679396","https://openalex.org/W2127251128","https://openalex.org/W2129716166","https://openalex.org/W2134535764","https://openalex.org/W2134639888","https://openalex.org/W2136365264","https://openalex.org/W2137758606","https://openalex.org/W2140993748","https://openalex.org/W2143527879","https://openalex.org/W2148900601","https://openalex.org/W2154808868","https://openalex.org/W2155742575","https://openalex.org/W2158409385","https://openalex.org/W2159773654","https://openalex.org/W2164918529","https://openalex.org/W2168358002","https://openalex.org/W2169609545","https://openalex.org/W2170172427","https://openalex.org/W2375600621","https://openalex.org/W4242401426","https://openalex.org/W6604546213"],"related_works":["https://openalex.org/W2140123048","https://openalex.org/W4319461385","https://openalex.org/W2112817451","https://openalex.org/W4415516990","https://openalex.org/W2617310531","https://openalex.org/W7117166999","https://openalex.org/W7100679791","https://openalex.org/W2112768419","https://openalex.org/W4390265649","https://openalex.org/W751336806"],"abstract_inverted_index":{"New":[0],"tuberculosis":[1,138],"drug":[2,9,48,94],"regimens":[3,139],"are":[4,42],"creating":[5],"new":[6,59,137,141],"priorities":[7],"for":[8,70,126],"susceptibility":[10],"testing":[11],"(DST)":[12],"and":[13,50,77,88,110,135,140,151],"surveillance.":[14],"To":[15],"minimise":[16],"turnaround":[17],"time,":[18],"rapid":[19],"DST":[20,65,86,100,114,142],"will":[21,31,79],"need":[22,32],"to":[23,44,51,55,83,89,92,122,147],"be":[24,68,120],"prioritised,":[25],"but":[26],"developers":[27],"of":[28,39,58,98,155],"these":[29,117],"assays":[30,101,118,143],"better":[33],"data":[34,76],"about":[35],"the":[36,153],"molecular":[37],"mechanisms":[38],"resistance.":[40],"Efforts":[41],"underway":[43],"link":[45],"mutations":[46],"with":[47,73],"resistance":[49],"develop":[52],"strain":[53],"collections":[54],"enable":[56],"assessment":[57],"diagnostic":[60],"assays.":[61],"In":[62],"resource-limited":[63],"settings,":[64],"might":[66],"not":[67],"appropriate":[69,85],"all":[71],"patients":[72],"tuberculosis.":[74],"Surveillance":[75],"modelling":[78,111],"help":[80],"country":[81],"stakeholders":[82],"design":[84],"algorithms":[87],"decide":[90],"whether":[91],"change":[93],"regimens.":[95],"Finally,":[96],"development":[97,134],"practical":[99],"is":[102,115],"needed":[103],"so":[104],"that,":[105],"in":[106],"countries":[107],"where":[108],"surveillance":[109],"show":[112],"that":[113],"advisable,":[116],"can":[119],"used":[121],"guide":[123],"clinical":[124],"decisions":[125],"individual":[127],"patients.":[128],"If":[129],"combined":[130],"judiciously":[131],"during":[132],"both":[133],"implementation,":[136],"have":[144],"enormous":[145],"potential":[146],"improve":[148],"patient":[149],"outcomes":[150],"reduce":[152],"burden":[154],"disease.":[156]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2124355658","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":5}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
